848413-77-4

Basic information

• Product Name: 3-Pyrrolidinecarboxamide, N-methoxy-N-methyl-1-(phenylmethyl)-
• CAS NO: 848413-77-4
• Molecular Formula: C14H20N2O2
• Molecular Weight: 248.325
• Mol File: 848413-77-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-Pyrrolidinecarboxamide, N-methoxy-N-methyl-1-(phenylmethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyrrolidinecarboxamide, N-methoxy-N-methyl-1-(phenylmethyl)-(848413-77-4)
• EPA Substance Registry System: 3-Pyrrolidinecarboxamide, N-methoxy-N-methyl-1-(phenylmethyl)-(848413-77-4)

Safety Data

• Hazardous Substances Data: 848413-77-4(Hazardous Substances Data)

Upstream product

• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 5747-92-2 1-benzyl-3-carboethoxypyrrolidine 
• 17012-21-4 1-benzylpyrrolidine-3-carboxylic acid methyl ester 

Downstream Products

• 1001070-35-4 C₂₅H₂₃N₃O₃S 
• 479090-19-2 3-(methoxy-methyl-carbamoyl)-pyrrolidine-1-carboxylic acid benzyl ester 
• 14398-99-3 (1-benzyl-pyrrolidin-3-yl)-phenyl-methanone 

Relevant articles and documents

AZAINDOLE DERIVATIVES WITH A COMBINATION OF PARTIAL NICOTINIC ACETYL-CHOLINE RECEPTOR AGONISM AND DOPAMINE REUPTAKE INHIBITION

Azaindole derivatives of formula (I): wherein the symbols have the meanings given in the specification, are described. These compounds have a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition. The invention also relates to pharmaceutical compositions containing these compounds, to methods for preparing them, methods for preparing novel intermediates useful for their synthesis, methods for preparing compositions, and uses of such compounds and compositions, for example, their use in administering them to patients to achieve a therapeutic effect in disorders in which nicotinic receptors and/or dopamine transporters are involved, or that can be treated via manipulation of those receptors

QUINOLONE ANTIBACTERIAL AGENTS

Compounds of formula I and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula I as well as pharmaceutically acceptable compositions comprising compounds of formula I. Compounds of formula I as disclosed herein can be used in a variety of applications including use as antibacterial agents.